Search
Close this search box.

Breakthrough in Biotech : Human Insulin Can Be Produced in Cow Milk – Here Is The Proof of Concept!

Human Insulin Can Be Produced in Cow Milk
Human Insulin Can Be Produced in Cow Milk
–Must See–

Bioinformatics Summer Internship 2024 With Hands-On-Training + Project / Dissertation - 30 Days, 3 Months & 6 Months Duration

Bioinformatics Summer Internship 2024 With Hands-On-Training + Project / Dissertation - 30 Days, 3 Months & 6 Months Duration

Producing Human Insulin in Cow’s Milk: Breakthrough in Biotechnology

A path-breaking study has demonstrated the feasibility of producing human insulin in cow’s milk, potentially revolutionizing the insulin production industry and addressing supply scarcity issues and high costs for individuals with diabetes. This innovative approach could lead to a more sustainable and cost-effective method of insulin production, led by researchers from the University of Illinois Urbana-Champaign and the Universidade de São Paulo. Let’s dive into the details of this remarkable advancement in biotechnology.

Harnessing Nature’s Efficiency

Nature has inherently designed the mammary gland as a highly efficient protein production factory. Leveraging this natural system, researchers sought to utilize cows as biofactories for producing human insulin. Matt Wheeler, a professor at the University of Illinois, Overlooked this study, aiming leverage the potential of cow’s milk as a source of insulin on a large scale.

The Genetic Engineering Process: From DNA Insertion to Milk Production

In this study, a segment of human DNA responsible for encoding proinsulin—a precursor to active insulin—was introduced into the cell nuclei of cow embryos. By targeting the expression of human DNA, specifically in mammary tissue, researchers were able to ensure that human insulin was produced solely in the

milk of the transgenic cow, with minimal impact on other bodily tissues.

Schematic of the lentiviral vector constructed for mammary gland-specific human insulin expression and restriction map analysis. (A) Schematic of the lentiviral vector constructed. (B) The restriction map for the vector, L- ladder 1 kb plus (Life Technologies < Waltham, MA); V- constructed vector digested with BamHI, ClaI, and XhoI restriction enzymes. The fragment of the hINS gene was generated by cleavage of the BamHI and XhoI enzymes, while BamHI and ClaI generated the fragment of the β-casein promoter, and the ClaI and XhoI enzymes generated the fragment from the original vector pLenti6.2-GW/EmGFP (7.833 kb). The size of the β-casein promoter used was 5.335 kb and the human proinsulin gene fragment was 1.193 kb. Credit: Biotechnology Journal (2024). DOI: 10.1002/biot.202300307

Results: Detection of Human Insulin in Cow’s Milk

Upon reaching maturity, the transgenic cow began lactating, yielding milk that contained detectable levels of human proinsulin and insulin. Surprisingly, the cow efficiently processed proinsulin into biologically active insulin, with a ratio of approximately three to one. This unexpected production of insulin directly in the mammary gland showed the remarkable capabilities of this bioengineered system.

Potential for Large-Scale Insulin Manufacturing

While the current study demonstrated the proof of concept for human insulin production in cow’s milk, the researchers are optimistic about scaling up the process for commercialization. Plans to clone the cow and optimize future lactation cycles aim to increase the efficiency and volume of insulin production. The vision includes establishing a purpose-built herd of transgenic cows that could supply a significant portion of the world’s insulin demand.

Toward a Sustainable Future: Implications for Insulin Supply and Accessibility

The successful implementation of this technology could offer a sustainable and cost-effective solution to the global insulin supply challenge. With the potential to establish transgenic herds capable of producing insulin at a substantial scale, this approach could revolutionize the insulin manufacturing industry. Additionally, using cows as biofactories aligns with existing dairy industry practices, ensuring a seamless integration of this innovative method.

Paving the Way for Enhanced Insulin Production

As researchers continue to refine and optimize the process of producing human insulin in cow’s milk, the future of insulin manufacturing appears promising. With a focus on efficiency, scalability, and sustainability, this bioengineered approach could transform the landscape of insulin production, offering hope for enhanced accessibility and affordability for individuals with diabetes worldwide.

Keywords: human insulin, cow’s milk, biotechnology, insulin production, genetic engineering, mammary gland, transgenic cows, scalability, sustainable insulin supply.